173 related articles for article (PubMed ID: 17078868)
1. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
Pan Y; Wang L; Dai JL
Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
[TBL] [Abstract][Full Text] [Related]
3. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
[TBL] [Abstract][Full Text] [Related]
4. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
5. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
[TBL] [Abstract][Full Text] [Related]
6. EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity.
Zheng JF; Sun LC; Liu H; Huang Y; Li Y; He J
Amino Acids; 2010 Apr; 38(4):1261-8. PubMed ID: 20012548
[TBL] [Abstract][Full Text] [Related]
7. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
8. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
Wang JQ; Qin F; Zhu L
J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
[TBL] [Abstract][Full Text] [Related]
9. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
Bouker KB; Skaar TC; Riggins RB; Harburger DS; Fernandez DR; Zwart A; Wang A; Clarke R
Carcinogenesis; 2005 Sep; 26(9):1527-35. PubMed ID: 15878912
[TBL] [Abstract][Full Text] [Related]
11. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
Bellizzi A; Mangia A; Malfettone A; Cardone RA; Simone G; Reshkin SJ; Paradiso A
Histopathology; 2011 Jun; 58(7):1086-95. PubMed ID: 21707710
[TBL] [Abstract][Full Text] [Related]
12. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.
Bellizzi A; Greco MR; Rubino R; Paradiso A; Forciniti S; Zeeberg K; Cardone RA; Reshkin SJ
Int J Oncol; 2015 Mar; 46(3):1214-24. PubMed ID: 25530180
[TBL] [Abstract][Full Text] [Related]
13. Biological role of NHERF1 protein expression in breast cancer.
Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
[TBL] [Abstract][Full Text] [Related]
14. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
[TBL] [Abstract][Full Text] [Related]
15. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract][Full Text] [Related]
17. Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdown.
Zhang L; Huang XH; Zhou PP; Yu GL; Yan J; Qin B; Yan XG; Diao LM; Lin P; Kuang YQ
Dongwuxue Yanjiu; 2015 May; 36(3):161-6. PubMed ID: 26018859
[TBL] [Abstract][Full Text] [Related]
18. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
